translocation RCC

• 

Treatment of translocation kidney cancer

By Sharon Deveson Kell|2023-11-13T12:00:08+00:0013 Nov 2023|Drug treatments|

Translocation kidney cancer is a rare type of kidney cancer [...]

Read More

Comments Off on Treatment of translocation kidney cancer

• 

Pembrolizumab plus lenvatinib for non-clear cell kidney cancer

By Sharon Deveson Kell|2023-10-02T08:53:12+00:002 Oct 2023|Drug treatments|

Immunotherapy combinations are becoming the standard treatment for people with [...]

Read More

Comments Off on Pembrolizumab plus lenvatinib for non-clear cell kidney cancer

• 

Efficacy of cabozantinib in metastatic MiT family translocation renal cell carcinoma

By Sharon Deveson Kell|2022-08-23T14:44:26+00:0023 Aug 2022|Drug treatments|

MiT family translocation renal cell carcinoma is a rare and [...]

Read More

Comments Off on Efficacy of cabozantinib in metastatic MiT family translocation renal cell carcinoma

• 

EIKCS 2022: Treatment for non-clear cell kidney cancer subtypes

By Sharon Deveson Kell|2022-04-26T08:39:32+00:0026 Apr 2022|Drug treatments, Subtypes of RCC|

At the European International Kidney Cancer Symposium (EIKCS) in Antwerp, [...]

Read More

Comments Off on EIKCS 2022: Treatment for non-clear cell kidney cancer subtypes

• 

Atezolizumab and bevacizumab for non-clear cell renal cell carcinoma

By Sharon Kell|2020-04-06T10:00:28+00:006 Apr 2020|Uncategorized|

In this video interview from Practice Update, Dr Brad McGregor [...]

Read More

Comments Off on Atezolizumab and bevacizumab for non-clear cell renal cell carcinoma

• 

Nivolumab for the treatment of metastatic non-clear cell renal cell carcinoma

By Sharon Kell|2020-03-25T09:40:03+00:0025 Mar 2020|Uncategorized|

Nivolumab alone and in combination with ipilimumab is used for [...]

Read More

Comments Off on Nivolumab for the treatment of metastatic non-clear cell renal cell carcinoma